Hematopoietic lineage cell‑specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinoma

Wenting Liu(Zhujiang Hospital), Fumitaka Kikkawa(Nagoya University)
Oncology Letters
April 13, 2018
Cited by 2


Related Papers